JP7541923B2 - 微粉化された１，４－ジ（ベンゾオキサゾール－２’－イル）ベンゼン - Google Patents

微粉化された１，４－ジ（ベンゾオキサゾール－２’－イル）ベンゼン Download PDF

Info

Publication number
JP7541923B2
JP7541923B2 JP2020545167A JP2020545167A JP7541923B2 JP 7541923 B2 JP7541923 B2 JP 7541923B2 JP 2020545167 A JP2020545167 A JP 2020545167A JP 2020545167 A JP2020545167 A JP 2020545167A JP 7541923 B2 JP7541923 B2 JP 7541923B2
Authority
JP
Japan
Prior art keywords
benzoxazol
benzene
aqueous dispersion
range
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020545167A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019180042A5 (https=
JP2021516678A5 (https=
JP2021516678A (ja
Inventor
クリスティーン メンドロク－エディンガー，
アレクサンダー シュリフク－ポシャルコ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2021516678A publication Critical patent/JP2021516678A/ja
Publication of JPWO2019180042A5 publication Critical patent/JPWO2019180042A5/ja
Publication of JP2021516678A5 publication Critical patent/JP2021516678A5/ja
Application granted granted Critical
Publication of JP7541923B2 publication Critical patent/JP7541923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2020545167A 2018-03-20 2019-03-19 微粉化された１，４－ジ（ベンゾオキサゾール－２’－イル）ベンゼン Active JP7541923B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18162882 2018-03-20
EP18162882.7 2018-03-20
PCT/EP2019/056881 WO2019180042A1 (en) 2018-03-20 2019-03-19 Micronized 1,4-di(benzoxazol-2'-yl)benzene

Publications (4)

Publication Number Publication Date
JP2021516678A JP2021516678A (ja) 2021-07-08
JPWO2019180042A5 JPWO2019180042A5 (https=) 2022-01-20
JP2021516678A5 JP2021516678A5 (https=) 2022-01-20
JP7541923B2 true JP7541923B2 (ja) 2024-08-29

Family

ID=61731610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020545167A Active JP7541923B2 (ja) 2018-03-20 2019-03-19 微粉化された１，４－ジ（ベンゾオキサゾール－２’－イル）ベンゼン

Country Status (6)

Country Link
US (1) US11958836B2 (https=)
EP (1) EP3768233B1 (https=)
JP (1) JP7541923B2 (https=)
KR (1) KR102826149B1 (https=)
CN (1) CN111902126A (https=)
WO (1) WO2019180042A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220346377A1 (en) * 2019-09-11 2022-11-03 Dsm Ip Assets B.V. Novel compositions
WO2026068529A1 (en) 2024-09-24 2026-04-02 Basf Se Topical compositions comprising terephthalylidene dicamphor sulfonic acid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002039972A1 (fr) 2000-11-17 2002-05-23 L'oreal Filtres uv organiques insolubles et leur utilisation en cosmetique
JP2003192557A (ja) 2001-12-07 2003-07-09 L'oreal Sa 遮蔽剤の相乗混合物をベースにした抗日光化粧品用組成物及びその用途
JP2017101091A (ja) 2014-04-02 2017-06-08 御国色素株式会社 紫外線吸収剤分散体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403451D0 (en) 1994-02-23 1994-04-13 Ciba Geigy Ag Sunscreen compositions
GB9515048D0 (en) 1995-07-22 1995-09-20 Ciba Geigy Ag Sunscreen compositions
US6030607A (en) * 1997-04-08 2000-02-29 Biocycle Laboratories, Inc. Water soluble sun tanning solution
CA2315544A1 (en) * 2000-08-08 2002-02-08 Alan K. Olson Fracturing method using aqueous or acid based fluids
JP2011528022A (ja) * 2008-07-16 2011-11-10 ディーエスエム アイピー アセッツ ビー．ブイ． 化粧品組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002039972A1 (fr) 2000-11-17 2002-05-23 L'oreal Filtres uv organiques insolubles et leur utilisation en cosmetique
JP2003192557A (ja) 2001-12-07 2003-07-09 L'oreal Sa 遮蔽剤の相乗混合物をベースにした抗日光化粧品用組成物及びその用途
JP2017101091A (ja) 2014-04-02 2017-06-08 御国色素株式会社 紫外線吸収剤分散体

Also Published As

Publication number Publication date
US11958836B2 (en) 2024-04-16
CN111902126A (zh) 2020-11-06
EP3768233A1 (en) 2021-01-27
WO2019180042A1 (en) 2019-09-26
JP2021516678A (ja) 2021-07-08
EP3768233B1 (en) 2026-02-25
KR102826149B1 (ko) 2025-06-27
KR20200135813A (ko) 2020-12-03
BR112020018962A2 (pt) 2020-12-29
US20210009570A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
US11419804B2 (en) Sunscreen formulations optimized for the formation of vitamin D
JP7541923B2 (ja) 微粉化された１，４－ジ（ベンゾオキサゾール－２’－イル）ベンゼン
US20250161191A1 (en) Direct emulsion comprising a uv-screening agent, a lipophilic acrylic polymer, a fatty acid ester of a polyol and a carboxylic anionic surfactant
CN111867548B (zh) 表面组合物
JP5903213B2 (ja) 透過染料の結晶変態
KR102790477B1 (ko) 국소 조성물
CN101336870B (zh) 均三嗪衍生物
BR112020018962B1 (pt) 1,4-di(benzoxazol-2?-il)benzeno micronizado
US20100221199A1 (en) Sunscreen Cosmetics
EP1944012A1 (en) Sunscreen cosmetic composition
US20240350375A1 (en) Non-nano uv filter dispersions
BR112020018944B1 (pt) Composição tópica, uso de um 1,4 di(benzoxazol-2'- il)benzeno micronizado e método para reduzir a transferência de óleo(s) polar(es) para uma superfície

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221220

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230516

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230704

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240524

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240717

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240724

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240806

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240819

R150 Certificate of patent or registration of utility model

Ref document number: 7541923

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150